PROGENICS PHARMACEUTICALS INC 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Mar 4, 2014
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2014-03-03$4.70/sh+132,000$620,400→ 132,000 totalExercise: $4.70Exp: 2024-03-03→ Common Stock (132,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.